Stephan Lücke - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Stephan Lücke's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists todayStephan Lücke
Verified
Editor, Bibliomed Pflege
Essen
Beats
Social Justice , Racial Equity , Cultural Identity
Features
Content
Early metabolic response in sequential FDG-PET/CT under cetuximab is a predictive marker for clinical response in first-line metastatic colorectal cancer patients: results of the phase II REMOTUX trial
Early metabolic response in sequential FDG-PET/CT under cetuximab is a predictive marker for clinical response in first-line metastatic colorectal cancer patients: results of the phase II REMOTUX trial
Company Info
Bibliomed Pflege
, ,
Founded: